老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ascendis Pharma A/S

174.89
-0.0750-0.04%
盤後：174.890.00000.00%18:02 EDT
成交量：32.05萬
成交額：5,642.47萬
市值：105.90億
市盈率：-27.79
高：179.50
開：175.50
低：173.81
收：174.96
資料載入中...
總覽公司新聞公告
2020/05/08

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/04/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/23

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多